PRED-SKIN integrates multiple QSAR models trained on key events of the Adverse Outcome Pathway (AOP) for skin sensitization. The platform combines in chemico (DPRA), in vitro (KeratinoSens, h-CLAT, U-SENS), in vivo (LLNA), and human (HRIPT/HMT) endpoint models into a consensus prediction system trained on over 1,500 curated compounds.
The Integrated Testing Strategy (ITS) implements OECD 497 Defined Approaches, combining computational predictions with experimental data to provide GHS potency classification. The applicability domain assessment ensures predictions remain within the model's validated chemical space, supporting reliable and transparent results for cosmetic safety assessment and regulatory submissions.
Pred-Skin Predictor
SELECT ANALYSIS MODE
In silico AOP
Prediction of skin sensitization potential based on in silico analysis as Adverse Outcome Pathway (AOP) Key Events.
Partial ITS analysis
Hybrid approach combining DPRA experimental data with in silico predictions.
Full ITS analysis
Complete OECD 497 Integrated Testing Strategies for highest confidence predictions.



